Microglial depletion exacerbates motor impairment and dopaminergic neuron loss in a 6-OHDA model of Parkinson's disease (2023)
- Authors:
- USP affiliated authors: BRITTO, LUIZ ROBERTO GIORGETTI DE - ICB ; FERREIRA, ANA FLAVIA FERNANDES - ICB ; OLIVEIRA, JOSÉ FRANCIS DE - ICB ; SINGULANI, MONIQUE PATRICIO - FM
- Unidades: ICB; FM
- DOI: 10.1016/j.jneuroim.2023.578019
- Subjects: FISIOLOGIA; CAMUNDONGOS; MODELOS ANIMAIS DE DOENÇAS; DOENÇA DE PARKINSON; NEURÓGLIA; TOXINAS; COORDENAÇÃO MOTORA; RECEPTORES DOPAMINÉRGICOS; NEURÔNIOS MOTORES
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal of Neuroimmunology
- ISSN: 1872-8421
- Volume/Número/Paginação/Ano: v. 375, art. 578019, p. 1-11, 2023
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
- Licença: publisher-specific-oa
-
ABNT
PEREIRA, Carolina Parga Martins et al. Microglial depletion exacerbates motor impairment and dopaminergic neuron loss in a 6-OHDA model of Parkinson's disease. Journal of Neuroimmunology, v. 375, p. 1-11, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.jneuroim.2023.578019. Acesso em: 27 dez. 2025. -
APA
Pereira, C. P. M., Oliveira, J. F., Singulani, M. P., Ferreira, A. F. F., & Britto, L. R. G. de. (2023). Microglial depletion exacerbates motor impairment and dopaminergic neuron loss in a 6-OHDA model of Parkinson's disease. Journal of Neuroimmunology, 375, 1-11. doi:10.1016/j.jneuroim.2023.578019 -
NLM
Pereira CPM, Oliveira JF, Singulani MP, Ferreira AFF, Britto LRG de. Microglial depletion exacerbates motor impairment and dopaminergic neuron loss in a 6-OHDA model of Parkinson's disease [Internet]. Journal of Neuroimmunology. 2023 ; 375 1-11.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1016/j.jneuroim.2023.578019 -
Vancouver
Pereira CPM, Oliveira JF, Singulani MP, Ferreira AFF, Britto LRG de. Microglial depletion exacerbates motor impairment and dopaminergic neuron loss in a 6-OHDA model of Parkinson's disease [Internet]. Journal of Neuroimmunology. 2023 ; 375 1-11.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1016/j.jneuroim.2023.578019 - Mitochondrial abnormalities in neurological disorders
- Inhibition of TRPM2 by AG490 is neuroprotective in a Parkinson’s Disease animal model
- Neuroplasticity induced by the retention period of a complex motor skill learning in rats
- Inhibition of neuroinflammation by GIBH-130 (AD-16) reduces neurodegeneration, motor deficits, and proinflammatory cytokines in a hemiparkinsonian model
- The transient receptor potential melastatin 2: a new therapeutical target for Parkinson’s disease?
- Most utilized rodent models for Alzheimer’s and Parkinson’s disease: a critical review of the past 5 years
- Modulação da plasticidade sináptica por TREK-1 e 5HT1A no estresse crônico pós-natal
- Deletion of the transient receptor potential Melastatin 2 gene mitigates the 6-hydroxydopamine-induced parkinson’s disease–like pathology
- Deletion of the transient receptor potential melastatin 2 gene mitigates the 6-hyydroxydopamine-induced Parkinson’s Disease–Like Pathology
- Neurodegeneration and glial morphological changes are both prevented by TRPM2 inhibition during the progression of a Parkinson's disease mouse model
Informações sobre o DOI: 10.1016/j.jneuroim.2023.578019 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
